Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
1 H NMR (500 MHz, CDCl 3 ) 8.037.98 (m, 1H), 7.867.81 (m, 1H), 7.667.60 (m, 2H), 7.437.36 (m, 4H), 6.96 (d, J = 16.0 Hz, 1H), 6.86 (d, J = 16.0 Hz, 1H), 6.80 (s, 1H), 3.16 (s, 2H), 2.58 (s, 2H), 2.43 (s, 2H), 2.33 (s, 3H), 1.59 (s, 6H), 1.06 (s, 6H) ppm
If you're ready to explore our premium collection, check out our Vitamins and Minerals to find the right fit for your health journey
We will continue treatments for the recommended time period but plan to switch to pills
Food and Drug Administration (FDA) approval of BRINSUPRI (brensocatib 10 mg and 25 mg tablets), the first approved treatment for non-cystic fibrosis bronchiectasis (NCFB) in adults and children aged 12 and older
Depending on findings, referral to a neurologist or diabetologist may be appropriate
Reproductive outcomes, endocrine endpoints such as androgen levels and menstrual regularity, and patient-centered outcomes were not assessed
